secwatch.observer — SEC 8-K summary
======================================

Issuer:     ABVC BIOPHARMA, INC. (ABVC)
CIK:        0001173313
Form:       8-K
Filed at:   2024-09-10T23:59:59+00:00
Accession:  0001213900-24-077361
Event type: regulatory
Sentiment:  neutral
Materiality: 0.30
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

ABVC Biopharma regains compliance with Nasdaq Shareholder Approval Rules
------------------------------------------------------------------------

- Received Nasdaq notification on Sept 6, 2024 confirming compliance with Listing Rules 5635(a)(1) and 5635(a)(2).
- Compliance based on Board Resolution dated May 16, 2024.
- Regained compliance for continued listing on Nasdaq Capital Market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1173313/000121390024077361/0001213900-24-077361-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1173313/000121390024077361/ea0214114-8k_abvcbio.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-077361

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer